Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Greenwillow Capital Management is a Singapore-based fund management firm specializing in real estate and technology investments, with a significant focus on the life sciences and healthcare sectors. The firm frequently collaborates with research institutions, notably Singapore's Agency for Science, Technology and Research (A*STAR), to support the commercialization of deep-tech and medtech innovations. Greenwillow manages specialized funds that target early-to-growth stage startups in medical devices, diagnostics, and digital health. Their investment strategy emphasizes bridging the gap between academic research and global market entry, particularly within the Asia-Pacific region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Greenwillow Capital Management.